Skip to main content
Inify Laboratories AB logo

Inify Laboratories AB — Investor Relations & Filings

Ticker · INIFY ISIN · SE0017486103 LEI · 549300306YYJ3BX3VB98 ST Human health and social work activities
Open in API
Filings indexed 344 across all filing types
Latest filing 2026-06-08 Regulatory Filings
Country SE Sweden
Listing ST INIFY

About Inify Laboratories AB

https://www.inify.com/

Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. The company utilizes a fully digital, standardized, and AI-supported workflow for histopathology analysis. This integrated service model is designed to optimize the entire diagnostic process, from sample receipt to final report, ensuring high quality and significantly reduced turnaround times for clinical partners. Initially focused on prostate cancer, the company has expanded its diagnostic capabilities to include other areas such as gastroenterology. By streamlining the clinical pathway, Inify Laboratories enables healthcare providers to receive faster results, which facilitates earlier patient follow-up and treatment planning.

Recent filings

Filing Released Lang Actions
Inify Laboratories signs agreement with University Hospitals Plymouth NHS Trust to support faster prostate cancer diagnostics
Regulatory Filings Classification · 92% confidence The document is a press release-style stock exchange announcement under MAR regarding a service agreement between Inify Laboratories and a hospital. It contains no financial results, statements, or voting details, and instead is a general regulatory announcement of a corporate partnership. This fits the fallback category Regulatory Filings (RNS).
2026-06-08 English
Inify Laboratories signs agreement with University Hospitals Plymouth NHS Trust to support faster prostate cancer diagnostics - Attachment: Inify_signs_agreement_with_University_Hospitals_Plymouth_NHS
Regulatory Filings Classification · 92% confidence The document is a stock exchange announcement under EU Market Abuse Regulation, disclosing a commercial agreement with University Hospitals Plymouth NHS Trust. It contains no financial statements, management changes, or regulatory certifications, nor is it a formal report (e.g., annual, interim, proxy). It is a general regulatory announcement, so it falls under the fallback category "Regulatory Filings (RNS)."
2026-06-08 English
Inify Laboratories signs agreement with University Hospitals Plymouth NHS Trust to support faster prostate cancer diagnostics
Regulatory Filings Classification · 90% confidence The document is a corporate press release/stock exchange announcement under MAR Article 17, notifying the market of an agreement between Inify Laboratories and a hospital trust. It does not contain financial statements, governance rules, dividends, or any other specialized filing content. It is published as a stock exchange announcement (“This stock exchange announcement was published by…”), making it a general regulatory announcement. Therefore, it falls under the Regulatory Filings (RNS) category.
2026-06-08 English
Inify Laboratories announces CQC registration and full operational launch of its state-of-the-art UK histopathology laboratory - Attachment: Inify_Laboratories_CQC_registration.pdf
Regulatory Filings Classification · 30% confidence The document is a corporate press release announcing the Care Quality Commission (CQC) registration and operational launch of a UK histopathology laboratory. It does not contain financial results, governance changes, regulatory filings, or other specialized content. It is not reporting on voting, shares, dividends, or transactions, nor is it an investor presentation or annual/interim report. Therefore, it does not fit any specific category and defaults to the general regulatory/press announcement category.
2026-05-27 English
Inify Laboratories announces CQC registration and full operational launch of its state-of-the-art UK histopathology laboratory
Regulatory Filings Classification · 65% confidence The document is a public press release announcing the company’s successful registration with the Care Quality Commission and the full operational launch of its new UK laboratory. It does not contain financial statements, management or board changes, M&A details, share issues, or quarterly results. It is a general regulatory/operational announcement rather than a formal financial report or shareholder document. Thus it falls under the generic Regulatory Filings category (RNS).
2026-05-27 English
Inify Laboratories AB (publ) - Bulletin from the Annual General Meeting 2026 - Attachment: Inify_Laboratories_Bulletin_from_Annual_General_Meeting_2026.pdf
AGM Information Classification · 91% confidence The document is titled “Bulletin from the Annual General Meeting 2026” and provides a summary of the resolutions adopted at the AGM (adoption of accounts, disposition of financial results, discharge from liability, remuneration, board elections, etc.). It is a post‐meeting summary of AGM resolutions rather than the full annual report or an earnings release. It is not announcing publication of a report nor detailing vote counts, so it best fits the AGM Information category.
2026-05-21 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.